Funder
Ministerstvo zdravotnictví České republiky
Reference38 articles.
1. Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality;Erqou;Jama,2009
2. Extreme lipoprotein(a) levels and improved cardiovascular risk prediction;Kamstrup;J Am Coll Cardiol,2013
3. Genetic variants associated with Lp(a) lipoprotein level and coronary disease;Clarke;N Engl J Med,2009
4. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: the task force for the management of dyslipidaemias of the European society of cardiology (ESC) and European atherosclerosis society (EAS);Mach;European Heart J,2019
5. Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease. A report of the American college of cardiology/American Heart Association Task Force on Clinical Practice Guidelines. 2019;74:e177-e232.
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献